ArticleClinical case reports2020
Rectus sheath hematoma in patients receiving subcutaneous enoxaparin: A case series of five patients.
Article in Clinical case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Bilateral rectus sheath hematoma following enoxaparin administration in a patient with extensive lower limb DVT: a rare complication.Journal of cardiothoracic surgery · 2026Article
- Intra-abdominal hematomas and identifiable risk factors in patients receiving subcutaneous enoxaparin.PloS one · 2024Article
- Hypovolemic shock due to rectus sheath hematoma secondary to subcutaneous low molecular weight heparin: a case report.Acta bio-medica : Atenei Parmensis · 2022Article
- Rectus Sheath Hematoma in COVID-19 Patients as a Mortal Complication: A Retrospective Report.International journal of clinical practice · 2022Article
- Rectus Sheath Hematoma Due to Low Molecular Weight Heparin in a COVID-19 Patient in Turkey.Cureus · 2021Article
- Rectus sheath hematoma in patients receiving subcutaneous enoxaparin: A case series of five patients.Clinical case reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Physicians must acknowledge the potential risk of RSH with enoxaparin. Switching home anticoagulation by enoxaparin upon hospital admission is common, but it may put patients at higher risk for RSH. Management guidelines are needed in this setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.